This Virtual Grand Rounds series examines research and advances across a variety of psychiatric conditions. It addresses many clinical challenges and barriers to treatment. These twenty sessions are ideal education for professionals in psychiatry, primary care, nursing, psychology and family practice.

In fact, you can use this free series to educate your entire staff in a community hospital or practice of any size. Or simply stay up-to-date as an individual clinician. The series provides CME/CE credits for physicians, psychologists, nurses and social workers. Each session includes live Q&A with faculty and is also available on-demand. You can view the entire series or a single session at any time during the year.

Every session is led by clinician-researchers from the Massachusetts General Hospital Department of Psychiatry. These are just a few of the topics the series addresses:

  • Novel approaches to treating depression.
  • Effective strategies for treating psychosis in the context of mood disorders
  • Diagnosis and treatment of Mood Disorders in patients with Attention Deficit Hyperactivity Disorder (ADHD)
  • Mood Disorders and sleep.
  • Mood Disorders and substance use.
  • Bipolar Disorder or ADHD? Implications for diagnosis and treatment.
  • Pharmacogenomics testing for refractory depression
  • Treating the "other" symptoms in Mood Disorders _ low energy, low appetite, and others
  • ECT and rTMS _ novel treatments

The on-demand version of the webinars will be available starting on the Monday following the broadcast.

For technical help please see the documentVirtual Grand Rounds Broadcast Instructions under the Resource Library tab.

Overall Learning Objectives

At the end of this educational activity, participants should be able to:

  • Identify novel and innovative evidence-based psychopharmacological strategies for treating depression.
  • Review contemporary strategies for assessing and managing sleep disorders in the context of mood disorders.
  • Review the current evidence-based assessment and treatment of schizophrenia and psychosis in the context of mood symptoms.
  • Review effective, research-driven strategies for identifying and treating opiate use disorders and other substance use disorders in the context of other psychiatric disorders.
  • Recognize bipolar disorder in the context of ADHD.
  • Describe the role of ECT and rTMS in the treatment of psychiatric illness.
  • Recognize and manage barriers to effective treatment of mood disorders including symptoms of fatigue, anorexia, and others.
  • Review the benefits and limitations of pharmacogenetic testing to guide choice of pharmacotherapy in the treatment of psychiatric disorders.

Target Audience

This program is intended for:

  • Physicians
  • Psychologists
  • Primary care/family physicians
  • Clinical nurse practitioners
  • Allied health service providers

Free CME

We offer free CME on a variety of topics and in a variety of formats. See the full list at the link below.

View our full list of free CME course offerings


All sessions begin at 11 AM EST

Novel Approaches to Depression

1. Advances in treatment selection in major depressive disorder
September 11, 2019
Roy H. Perlis, MD, MSc

2. Challenges in the Diagnosis and Treatment of Schizophrenia and Bipolar Disorder in Youth
September 25, 2019
Janet Wozniak, MD

3. News from the pipeline: Innovative evidence-based treatments
October 9, 2019
Maurizio Fava, MD

Effective Strategies for Treating Psychosis in the Context of Mood Disorders

1. Addressing difficult to treat depression

October 23, 2019
George Papakostas, MD

2. Treating psychosis in depressive and bipolar disorders
November 6, 2019
Andrew A. Nierenberg, MD

Diagnosis and Treatment of Mood Disorders in Patients with ADHD

1. Differentiating Unipolar vs Bipolar Pediatric Depression
November 20, 2019
Joseph Biederman, MD

Management of Sleep in the Context of Mood Disorders

1. Sleep disorders and depressive illness
December 4, 2019
John W. Winkelman, MD

2. Pharmacology of sleep disorder management
December 18, 2019
John W. Winkelman, MD

Co-Occurring Substance Use Disorders and Mood Disorders

1. Management of OUD
January 8, 2020
Sarah E. Wakeman, MD

2. Pharmacological options for treating alcohol use disorder
January 22, 2020
Laura G. Kehoe, MD

Bipolar Disorder or ADHD? Implications for Diagnosis and Treatment

1. ADHD in Bipolar Disorder: Treatment Implications
March 4, 2020
Timothy E. Wilens, MD

Co-Occurring Substance Use Disorders and Mood Disorders

3. Neurobiology of addiction and treatment of nicotine use in the context of depressive disorders
February 5, 2019

Bipolar Disorder or ADHD? Implications for Diagnosis and Treatment

2. Diagnosis of ADHD in the context of bipolar disorder in adults
February 19, 2020
Tom Spencer, MD

Pharmacogenomics Testing for Refractory Depression

1. Pharmacogenetics and medication response
March 18, 2020
Robert R. Althoff, MD, PhD

Treating the "Other" Symptoms in Mood Disorders _ Low Energy, Low Appetite, and Others

1. Management of sexual symptoms in depression
April 1, 2020

2.Implications of Psychiatric Genetics for Psychopharmacology
April 15, 2020
Stephen V. Faraone, Ph.D.

3.Diagnosis, neurobiology, and treatment of avoidant/restrictive food intake disorder
April 29, 2020
Kendra R. Becker, PhD

4. Transcranial Magnetic Stimulation: principles and applications
May 13, 2020
Joan A. Camprodon, MD, PhD. MPH

ECT and rTMS - Innovative Therapies for Mood Disorders

1. ECT for depression
May 27, 2020
Michael Henry

2. Transcranial magnetic stimulation
June 10, 2020
Tracy A. Barbour, MD

CME Information

Release Date: September 11, 2019
Expiration Date: June 10, 2020






AMA PRA Category 1 CreditTM

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

McLean Hospital designates this enduring material for a maximum of 20.00AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Psychologists CE Credit

The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

This offering meets the criteria for 20.00 continuing education credits for psychologists.


Nursing Contact Hours

Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

This program meets the requirements of the Massachusetts Board of Registration in Nursing at (244 CMR 5.00) for 20.00 contact hours of nursing continuing education credit.

Other Professions

Other Providers can claim a Participation Certificate upon successful completion of this course.

Participation Certificates will specify the title, location, type of activity, date of activity, and number ofAMA PRA Category 1 CreditsTMassociated with the activity. Providers should check with their regulatory agencies to determine ways in whichAMA PRA Category 1 CreditsTMmay or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Planner Disclosures

The following planners and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:

David Rubin, MD, reviewer

Jane Pimental, MPH

The following planners and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:

Susan E. Sprich, PhD, psychologist reviewer
Royalties:Oxford University Press (for co-authoring treatment manual and client workbook), Springer (for editing book)

Roy H. Perlis, MD, MSc
Scientific Advisor: Genomind, Psy Therapeutics, Outermost Therapeutics, RID Ventures, Takeda

Janet Wozniak, MD
Research Support: PCORI
Royalties (Spouse): UptoDate
Consultation Fees (Spouse): Advance Medical, Gerson Lehman Group, Springer Healthcare
Research Support (Spouse): RLS Foundation, Merck


This program has received support in the form of educational grants from the following companies:

  • Alkermes
  • Takeda

Hardware/Software Specifications

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

Privacy Policy

Please click here to review our privacy policy.